Related references
Note: Only part of the references are listed.Transcatheters for closure of patent foramen ovales
Gianluca Rigatelli et al.
EXPERT REVIEW OF MEDICAL DEVICES (2018)
Percutaneous Closure of Patent Foramen Ovale in Migraine A Meta-Analysis of Randomized Clinical Trials
Babikir Kheiri et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2018)
Cryptogenic Stroke and High-Risk Patent Foramen Ovale The DEFENSE-PFO Trial
Pil Hyung Lee et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Percutaneous patent foramen ovale closure for secondary stroke prevention Network meta-analysis
Georgios Tsivgoulis et al.
NEUROLOGY (2018)
Patent Foramen Ovale Closure for Stroke Prevention and Other Disorders
Fareed Moses S. Collado et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2018)
Optimal stroke prevention in patients with patent foramen ovale
Bernhard Meier
LANCET NEUROLOGY (2018)
Patent Foramen Ovale Closure, A Contemporary Review
Raouf Madhkour et al.
STRUCTURAL HEART-THE JOURNAL OF THE HEART TEAM (2018)
Transcatheter Patent Foramen Ovale Closure After Cryptogenic Stroke An Updated Meta-Analysis of Randomized Trials
Mohammad Khalid Mojadidi et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2017)
Percutaneous Closure of Patent Foramen Ovale in Patients With Migraine The PREMIUM Trial
Jonathan M. Tobis et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Patent Foramen Ovale Closure or Antiplatelet Therapy for Cryptogenic Stroke
Lars Sondergaard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Long-Term Outcomes of Patent Foramen Ovale Closure or Medical Therapy after Stroke
Jeffrey L. Saver et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Patent Foramen Ovale Closure or Anticoagulation vs. Antiplatelets after Stroke
J. -L. Mas et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Second transcatheter closure for residual shunt following percutaneous closure of patent foramen ovale
Njomeza Susuri et al.
EuroIntervention (2017)
AMPLATZER versus Figulla occluder for transcatheter patent foramen ovale closure
Daniela Trabattoni et al.
EUROINTERVENTION (2017)
Percutaneous closure of patent foramen ovale in migraine with aura, a randomized controlled trial
Heinrich P. Mattle et al.
EUROPEAN HEART JOURNAL (2016)
Physiological impact of patent foramen ovale on pulmonary gas exchange, ventilatory acclimatization, and thermoregulation
Andrew T. Lovering et al.
JOURNAL OF APPLIED PHYSIOLOGY (2016)
Practice advisory: Recurrent stroke with patent foramen ovale (update of practice parameter): Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology
Steven R. Messe et al.
NEUROLOGY (2016)
Single Center Experience: Implantation Failures, Early, and Late Complications After Implantation of a Partially Biodegradable ASD/PFO-Device (BioStar®)
Christoph M. Happel et al.
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS (2015)
Embolic strokes of undetermined source: the case for a new clinical construct
Robert G. Hart et al.
LANCET NEUROLOGY (2014)
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
Walter N. Kernan et al.
STROKE (2014)
Long-term results of a randomized trial comparing three different devices for percutaneous closure of a patent foramen ovale
Marius Hornung et al.
EUROPEAN HEART JOURNAL (2013)
Antithrombotic and Thrombolytic Therapy for Valvular Disease Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
Richard P. Whitlock et al.
CHEST (2012)
Long-term risk of recurrent stroke in young cryptogenic stroke patients with and without patent foramen ovale
Antonio Arauz et al.
INTERNATIONAL JOURNAL OF STROKE (2012)
Some Air for Closure of the Patent Foramen Ovale
Bernhard Meier
JACC-CARDIOVASCULAR INTERVENTIONS (2012)
Meta-Analysis of Transcatheter Closure Versus Medical Therapy for Patent Foramen Ovale in Prevention of Recurrent Neurological Events After Presumed Paradoxical Embolism
Shikhar Agarwal et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2012)
PFO and Paradoxical Embolism Producing Events Other Than Stroke
Catherine N. Dao et al.
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS (2011)
Explantation of Patent Foramen Ovale Closure Devices A Multicenter Survey
Swarnendra K. Verma et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2011)
Microemboli May Link Spreading Depression, Migraine Aura, and Patent Foramen Ovale
Ala Nozari et al.
ANNALS OF NEUROLOGY (2010)
Patent Foramen Ovale Closure Using a Bioabsorbable Closure Device Safety and Efficacy at 6-Month Follow-Up
Ben J. Van den Branden et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2010)
Late Results After Percutaneous Closure of Patent Foramen Ovale for Secondary Prevention of Paradoxical Embolism Using the Amplatzer PFO Occluder Without Intraprocedural Echocardiography Effect of Device Size
Andreas Wahl et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2009)
Transseptal puncture for catheter ablation of atrial fibrillation after device closure of patent foramen ovale
Ruzbeh Zaker-Shahrak et al.
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS (2008)
Migraine intervention with STARFlex technology (MIST) trial - A prospective, multicenter, double-blind, sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache
Andrew Dowson et al.
CIRCULATION (2008)
Hypersensitivity reactions associated with endovascular devices
Golara Honari et al.
CONTACT DERMATITIS (2008)
Percutaneous closure of patent foramen ovale with a novel FlatStent™
Isabel Reiffenstein et al.
EXPERT REVIEW OF MEDICAL DEVICES (2008)
Patent Foramen ovale and high-altitude pulmonary edema
Yves Allemann et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
BioSTAR evaluation STudy (BEST) - A prospective, multicenter, phase I clinical trial to evaluate the feasibility, efficacy, and safety of the BioSTAR bioabsorbable septal repair implant for the closure of atrial-level shunts
Michael J. Mullen et al.
CIRCULATION (2006)
Instant percutaneous closure of patent foramen ovale in patients with acute myocardial infarction and normal coronary arteries
VK Mehan et al.
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS (2006)
Percutaneous closure of patent foramen ovale: impact of device design on safety and efficacy
M Schwerzmann et al.
HEART (2004)
Incidence and clinical course of thrombus formation on atrial septal defect and patient foramen ovale closure devices in 1,000 consecutive patients
U Krumsdorf et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
Pacman Sign during device closure of the patent foramen ovale
B Meier
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS (2003)
Nickel release after implantation of the amplatzer occluder
MW Ries et al.
AMERICAN HEART JOURNAL (2003)
Relation between directly detected patent foramen ovale and ischemic brain lesions in sport divers
M Schwerzmann et al.
ANNALS OF INTERNAL MEDICINE (2001)
Share Paper
